Amicus prices stock offering

• Amicus Therapeutics (NASDAQ:FOLD) prices its public offering of 13.85M shares of common stock at $6.50 per share. Underwriters over-allotment is 2,077,500 shares. Closing date is November 24, 2014.
• Proceeds will be used to build the commercialization infrastructure for migalstat monotherapy for Fabry disease, the continued clinical development of its pipeline and for general corporate purposes.